Trial Profile
Pharmacokinetics of Tigecycline in Patients Receiving Continuous Renal Replacement Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2023
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Community-acquired pneumonia; Intra-abdominal infections; Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- 15 Nov 2023 Status changed from recruiting to completed.
- 24 Aug 2018 New trial record